Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Spectranetics Device Wins Approval

Photonics Spectra
Jul 2012
Spectranetics Corp. of Colorado Springs, Colo., has received FDA approval for its GlideLight Laser Sheath for cardiac lead removal. GlideLight requires 55 percent less force to advance than the company’s SLS II laser sheath, which, in turn, needs significantly less force to advance than mechanical telescoping sheaths. “Mechanical force is a leading cause of complications during lead extraction, and reduced force improves the control for safely removing leads,” said Dr. Bruce Wilkoff, director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, and a nonpaid member of Spectranetics’ medical advisory board.

Businesscardiac lead removalFDA approvalGlideLight Laser Sheathlaserslight speedmechanical telescoping sheathsSLS II laser sheathSpectranetics Corp.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to Photonics Spectra magazine - FREE!